Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia
出版年份 2023 全文链接
标题
Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia
作者
关键词
-
出版物
Current Opinion in Endocrinology Diabetes and Obesity
Volume -, Issue -, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2023-10-30
DOI
10.1097/med.0000000000000842
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial
- (2023) Kausik K Ray et al. Lancet Diabetes & Endocrinology
- Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia
- (2023) Hayato Tada et al. ATHEROSCLEROSIS
- Patient adherence to fully reimbursed proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9i) treatment
- (2023) Alissia Stummer et al. WIENER KLINISCHE WOCHENSCHRIFT
- Impact of Patient Visualization of Cardiovascular Images on Modification of Cardiovascular Risk Factors
- (2023) Kristyn Whitmore et al. JACC-Cardiovascular Imaging
- Strategies of improving adherence to lipid-lowering therapy in patients with atherosclerotic cardiovascular disease
- (2023) Dean G. Karalis CURRENT OPINION IN LIPIDOLOGY
- Advantages and Disadvantages of Inclisiran: A Small Interfering Ribonucleic Acid Molecule Targeting PCSK9—A Narrative Review
- (2022) Iveta Merćep et al. Cardiovascular Therapeutics
- Prevalence of statin intolerance: a meta-analysis
- (2022) Ibadete Bytyçi et al. EUROPEAN HEART JOURNAL
- Reduction of cardiovascular events with the use of lipid-lowering medication in patients with familial hypercholesterolemia or severe primary hypercholesterolemia: A systematic review
- (2022) Walter Masson et al. Journal of Clinical Lipidology
- Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolaemia: Practical advice for the community clinician
- (2022) Ari E Horton et al. JOURNAL OF PAEDIATRICS AND CHILD HEALTH
- Nonadherence to lipid‐lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease
- (2022) Nihar R. Desai et al. CLINICAL CARDIOLOGY
- World Heart Federation Cholesterol Roadmap 2022
- (2022) Kausik K. Ray et al. Global Heart
- Adherence to statin treatment in patients with familial hypercholesterolemia: A dynamic prediction model
- (2022) Arjen J. Cupido et al. Journal of Clinical Lipidology
- Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study
- (2022) Rodrigo Alonso et al. European Journal of Preventive Cardiology
- Understanding how educational interventions improve treatment adherence in patients with familial hypercholesterolaemia: a systematic review
- (2022) Hannah Massey et al. Journal of Community Genetics
- LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial
- (2021) Antonio J. Vallejo-Vaz et al. ATHEROSCLEROSIS
- Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
- (2021) Antonio J. Vallejo-Vaz et al. LANCET
- Medication adherence in cardiovascular medicine
- (2021) Steven T Simon et al. BMJ-British Medical Journal
- Treatment Inertia in Patients With Familial Hypercholesterolemia
- (2021) Anatoly Langer et al. Journal of the American Heart Association
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
- (2020) Jan Borén et al. EUROPEAN HEART JOURNAL
- Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care
- (2020) Gerald F. Watts et al. Nature Reviews Cardiology
- Reasons for Nonadherence to Statins – A Systematic Review of Reviews
- (2020) Marianne Vie Ingersgaard et al. Patient Preference and Adherence
- Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National Registry
- (2020) Jing Pang et al. Heart Lung and Circulation
- Barriers, facilitators, and solutions to familial hypercholesterolemia treatment
- (2020) Laney K. Jones et al. PLoS One
- Association between Lipid Testing and Statin Adherence in the Veterans Affairs Health System
- (2019) Xiaoming Jia et al. AMERICAN JOURNAL OF MEDICINE
- Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system
- (2019) Rachelle Louise Cutler et al. Patient Preference and Adherence
- The patient journey with proprotein convertase subtilisin/kexin type 9 inhibitors in community practice
- (2019) Corey K. Bradley et al. Journal of Clinical Lipidology
- Enablers and barriers to treatment adherence in heterozygous familial hypercholesterolaemia: a qualitative evidence synthesis
- (2019) Fiona J Kinnear et al. BMJ Open
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia
- (2019) Ilse K. Luirink et al. NEW ENGLAND JOURNAL OF MEDICINE
- PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study
- (2019) Carlo Piccinni et al. CLINICAL DRUG INVESTIGATION
- Treatment goal attainment in children with familial hypercholesterolemia: A cohort study of 302 children in Norway
- (2018) Martin P. Bogsrud et al. Journal of Clinical Lipidology
- Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia
- (2018) Martin S. Hagger et al. ATHEROSCLEROSIS
- Adverse Events Associated With PCSK9 Inhibitors: A Real-World Experience
- (2018) Muhammed T. Gürgöze et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial
- (2018) Ulf Näslund et al. LANCET
- Statin-associated muscle symptoms—Managing the highly intolerant
- (2017) James M. Backes et al. Journal of Clinical Lipidology
- Consecución de objetivos terapéuticos de colesterol LDL en niños y adolescentes con hipercolesterolemia familiar. Registro longitudinal SAFEHEART
- (2017) Adriana Saltijeral et al. REVISTA ESPANOLA DE CARDIOLOGIA
- Association of Prior Authorization and Out-of-pocket Costs With Patient Access to PCSK9 Inhibitor Therapy
- (2017) Ann Marie Navar et al. JAMA Cardiology
- Drug treatment and adherence of subjects
- (2016) Manuela Casula et al. ATHEROSCLEROSIS
- Ezetimibe: Use, costs, and adverse events in Australia
- (2016) Samantha A. Hollingworth et al. Cardiovascular Therapeutics
- Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United StatesCLINICAL PERSPECTIVE
- (2016) Emil M. deGoma et al. Circulation-Cardiovascular Genetics
- Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia
- (2016) Leopoldo Perez de Isla et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statin Initiation During Childhood in Patients With Familial Hypercholesterolemia
- (2016) Marjet J.A.M. Braamskamp et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United StatesCLINICAL PERSPECTIVE
- (2016) Emil M. deGoma et al. Circulation-Cardiovascular Genetics
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- Long-Term Statin Treatment in Children with Familial Hypercholesterolemia: More Insight into Tolerability and Adherence
- (2015) Marjet J. A. M. Braamskamp et al. PEDIATRIC DRUGS
- Predicting non-adherence in patients with familial hypercholesterolemia
- (2014) J. M. H. Galema-Boers et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now